Serum of patients with neuropathy and IgM monoclonal antibodies (M-proteins) that bind to the myelin-associated glycoprotein (MAG) were tested for binding to the major cross-reactive sulfated glucuronic acid containing glycosphingolipid, sulfated glucuronic acid paragloboside (SGPG). IgM binding to the glycolipid was detectable at serum dilutions of 1 : 10 000 and reactivity was greatest at 4°C. Low titers of IgM binding to the glycolipid were also detected in sera from normal subjects and from patients with neurologic or rheumatologic diseases without serum M-proteins. Binding activity was prosent in 25% of the sera tested, and titers ranged between 1 : 25 and 1 : 400. One patient with peripheral neuropathy, however, had a measurable titer of 1 : 12 800 in the absence of monoclonal gammopathy. The study indicates that cold reacting anti-SGPG IgM antibodies are frequent constituents of the normal human antibody repertoire, and that monoclonal or polyclonal expansion of B cells that secrete these antibodies, is associated with peripheral neuropathy.
- Myelin-associated glycoprotein
- Peripheral neuropathy
- Sulfated glucuronic acid paragloboside
ASJC Scopus subject areas
- Immunology and Allergy
- Clinical Neurology